Survival outcomes of hepatectomy for stage B Hepatocellular carcinoma in the BCLC classification

Table 3 Multivariate analysis of variables predictive for stage B HCC patient recurrence

Recurrence	p value	Risk ratio	95% confidence interval
Albumin (g/dl), <4 vs ≥4	0.026	1.382	1.040	1.834
PIVKA-II (mAU/ml), ≤100 vs >1000	0.437	0.537	0.266	0.983
100–1000 vs >1000	0.038	1.479	1.023	2.127
100–1000 vs ≤100	0.002	2.755	1.447	5.717
AP-factor, AP1 vs AP2	0.036	2.102	1.049	4.548
AP2 vs AP3	0.001	0.562	0.395	0.795
Tumor number, 1 vs 2,3	0.037	0.709	0.514	0.979
1 vs ≥4	<0.001	0.485	0.326	0.739
Microscopic portal vein invasion, vp0 vs vp2	0.006	0.488	0.310	0.805

PIVKA-II, protein induced by vitamin K absence or antagonism factor II; AP-factor, a product of the serum levels of AFP and PIVKA-II
vp0: no tumor thrombus in the portal vein
vp1: tumor thrombus distal to the second branches of the portal vein
vp2: tumor thrombus in the second branches of the portal vein

ISSN: 1477-7819